Due to ISMP Advocacy, VinCRIStine Labeling and Packaging Changed to Prevent Wrong Route Administration

ISMP commends the U.S. Food and Drug Administration for requesting that Pfizer revise its current prescribing information and product packaging for vinCRIStine to eliminate syringe administration.

ISMP Warns about Medication Safety Issues with Drug Shortage Replacement Products

Practitioners should be prepared to take extra precautions with vials of neuromuscular blocking agents without the usual “Warning: Paralyzing Agent” statement required on vial caps and a propofol p...

ISMP Shares Announcement Neuromuscular Blocking Agents Will Not Carry Safety Alert Caps Due to COVID-19 Demand

This article appeared on the Anesthesia Patient Safety Foundation website on June 5, 2020.

ISMP Issues Alert on Remdesivir Labeling, Propofol Dosing

This article appeared on the Infectious Disease Special Edition website on May 20, 2020.

Push Is on to Make IV Workflow Systems Universal

This article appeared on the Pharmacy Practice News website on May 19, 2020.

FDA Aims to Thwart Infusion Pump Shortage with Industrywide Emergency Use Authorization

This article appeared on the MedTech Dive website on May 15, 2020.